Deep Blue BioTech
PrivateLast Round
Grant
Oct 20, 2025
Total Funding Raised
$1.65M
Company Overview
Deep Blue BioTech operates in Healthcare & Life Sciences and is based in Stowmarket. Its latest recorded funding round was a Grant round in October 2025.
Deep Blue BioTech is a biotechnology company that develops a synthetic biology platform to produce carbon-neutral chemicals using photosynthetic cyanobacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Blue BioTech Comparables
Compare Deep Blue BioTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aura Life Science | 82% | |
| Enzymit | 80% | |
| Bravely Cultured | 79% |
For institutional investors. Book with your work email.
Deep Blue BioTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 20, 2025 | ||||
| Pre Seed | Oct 29, 2024 | ||||
| Accelerator | Jul 1, 2024 | ||||
| Grant | Feb 1, 2024 | ||||
| Pre Seed | Oct 5, 2023 | ||||
Accelerator | May 1, 2023 |
For institutional investors. Book with your work email.
Deep Blue BioTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Sustainable Ventures | Pre Seed |
| Innovate UK | Grant |
| The Greenhouse | Accelerator |
| SFC Capital | Pre Seed |
| One Planet Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 146% MoM, reaching 1.5K.
- Apr 15, 2026
Monthly visitors increased 331% MoM.
For institutional investors. Book with your work email.
Deep Blue BioTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deep Blue BioTech's valuation, stock price, and market status.
Is Deep Blue BioTech a public or private company?
Deep Blue BioTech is a private company.
What is the current stock price of Deep Blue BioTech?
Deep Blue BioTech is a private company, so its shares have no public market price. Caplight tracks Deep Blue BioTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deep Blue BioTech worth (valuation)?
Valuation information for Deep Blue BioTech is not publicly available.
Can I buy Deep Blue BioTech stock?
Deep Blue BioTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deep Blue BioTech's last funding round?
Deep Blue BioTech's most recent funding round was Grant on October 20, 2025.
Who are the main investors in Deep Blue BioTech?
Key investors in Deep Blue BioTech include Sustainable Ventures.
Will Deep Blue BioTech IPO soon?
No public IPO plans have been announced for Deep Blue BioTech.
How can I track Deep Blue BioTech secondary market activity?
Caplight tracks bids, offers, and trades in Deep Blue BioTech's shares on secondary markets.